Ali Taghizadeh Announces DMD ANKA mRNA Therapy, Currently in Clinical Trial in Turkiye
Turkish pharmacologist Assoc. Prof. Dr. Ali Taghizadeh announced in English to his followers abroad the mRNA therapy he is working on for Duchenne Muscular...
Lymphatic System Could be Driving Force Behind DMD Progression
In two recent studies, a team of scientists under the guidance of Mendell Rimer, PhD, and Mariappan Muthuchamy, PhD, at the Texas A&M University...
Blood Biomarkers Could Offer More Tailored Treatment for Duchenne Muscular Dystrophy
Researchers from the University of Florida and Leiden University Medical Center (LUMC) have discovered hundreds of blood proteins in DMD patients that show the...
Researchers at The University of Minnesota Find a New Way to Treat Duchenne Muscular Dystrophy: Bottlebrush Polymer
A novel strategy has been discovered by researchers at the University of Minnesota Medical School and the College of Science and Engineering that may...
WVE-N531 Exon Skipping Therapy Phase 2 Clinical Trial Begins for Duchenne Muscular Dystrophy
Wave Life Sciences Ltd. announced on its ClinicalTrials.gov website that a phase 2 clinical trial of WVE-N531 (Exon 53 Skipping Therapy) will begin in...